Abiraterone acetate can cause developmental toxicity, female reproductive toxicity and male reproductive toxicity according to state or federal government labeling requirements. Abiraterone acetate is a sterol ester obtained by formal condensation of the 3-hydroxy group of abiraterone with the carboxy group of acetic acid. A prodrug that is converted in vivo into abiraterone. It is grouped under the following drug class(es): Antineoplastic agents. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Zytiga, Yonsa and 3-Epiabiraterone Acetate. Its PubChem CID is 9821849.
Abiraterone acetate
| CAS No | 154229-18-2 |
|---|---|
| Molecular Formula | C26H33NO2 |
| Molecular Weight | 391.5 g/mol |
| Synonyms | [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Abiraterone acetate can cause developmental toxicity, female reproductive toxicity and male reproductive toxicity according to state or federal government labeling requirements.
The listed CAS number is 154229-18-2.
The listed molecular formula is C26H33NO2.
The listed molecular weight is 391.5 g/mol.
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.
The source lists Zytiga, Yonsa and 3-Epiabiraterone Acetate.